Chengdu Easton Biopharmaceuticals Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 314.99 million compared to CNY 277.85 million a year ago. Revenue was CNY 314.99 million compared to CNY 277.85 million a year ago.

Net income was CNY 75.01 million compared to CNY 60.99 million a year ago. Basic earnings per share from continuing operations was CNY 0.63 compared to CNY 0.51 a year ago. Diluted earnings per share from continuing operations was CNY 0.63 compared to CNY 0.51 a year ago.